Mark Crockett, MDMolecular ImagingTargeted radiopharmaceuticals offer new hope for longer 'healthspans'Precision radiopharmaceuticals accurately target tumors while minimizing damage to healthy tissue, presenting an opportunity to extend not just lifespans but “healthspans,” Mark Crockett, MD, explains in this article.March 15, 2024Page 1 of 1Top StoriesRadiation Oncology/TherapyASTRO applauds new legislation on radiation therapy paymentsThe American Society for Radiation Oncology (ASTRO) applauded the introduction of legislation in Congress on May 15 that could radically change the way Medicare pays for radiation therapy.MRILow sexual desire manifests as dimorphic brain processing on fMRIPractice ManagementX-ray vision: The complexities of radiology revenue cycle managementWomens ImagingCan positive leadership combat burnout among radiologists?Sponsor ContentIMV’s Oncology in Diagnostic Imaging Market Outlook Report